Notice2024-22948
Request for Information (RFI): To Inform the Development of the 2026-2030 National HIV/AIDS Strategy and the National Strategic Plans for Sexually Transmitted Infections, Vaccines, and Viral Hepatitis
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 7, 2024
Issuing agencies
Health and Human Services Department
Abstract
Through this Request for Information (RFI), the Office of Infectious Disease and HIV/AIDS Policy (OIDP) in the Office of the Assistant Secretary for Health (OASH) in the Office of the Secretary, Department of Health and Human Services (HHS), invites feedback from Federal, State, Tribal, territorial, and local governments; community- based organizations and faith-based organizations; Urban Indian Organizations; health plans and payers; health care providers, and other health-related and social services organizations; private-sector entities; researchers and academic institutions; people living with and who experience risk for disease; and other interested constituents on Strategic Plans to serve as national roadmaps to guide efforts to address HIV, sexually transmitted infections (STI), and viral hepatitis, and to improve and enhance the development and use of vaccines in the United States.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 194 (Monday, October 7, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 194 (Monday, October 7, 2024)]
[Notices]
[Pages 81087-81088]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-22948]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Request for Information (RFI): To Inform the Development of the
2026-2030 National HIV/AIDS Strategy and the National Strategic Plans
for Sexually Transmitted Infections, Vaccines, and Viral Hepatitis
AGENCY: Office of Infectious Disease and HIV/AIDS Policy, Office of the
Assistant Secretary for Health, Office of the Secretary, Department of
Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Through this Request for Information (RFI), the Office of
Infectious Disease and HIV/AIDS Policy (OIDP) in the Office of the
Assistant Secretary for Health (OASH) in the Office of the Secretary,
Department of Health and Human Services (HHS), invites feedback from
Federal, State, Tribal, territorial, and local governments; community-
based organizations and faith-based organizations; Urban Indian
Organizations; health plans and payers; health care providers, and
other health-related and social services
[[Page 81088]]
organizations; private-sector entities; researchers and academic
institutions; people living with and who experience risk for disease;
and other interested constituents on Strategic Plans to serve as
national roadmaps to guide efforts to address HIV, sexually transmitted
infections (STI), and viral hepatitis, and to improve and enhance the
development and use of vaccines in the United States.
DATES: To be assured consideration, comments must be received at the
addresses provided below, no later than 5:00 p.m. ET on December 6,
2024.
ADDRESSES: Submissions must be submitted electronically via the
following website: <a href="https://app.smartsheetgov.com/b/form/68aa1bd9c54b42829f99e85cc4ab1e82">https://app.smartsheetgov.com/b/form/68aa1bd9c54b42829f99e85cc4ab1e82</a>.
FOR FURTHER INFORMATION CONTACT: Questions about this RFI should be
directed to Nathan Fecik; Phone: 202-795-7616; Email:
<a href="/cdn-cgi/l/email-protection#4b1832252f2e262228380b232338652c243d"><span class="__cf_email__" data-cfemail="ca99b3a4aeafa7a3a9b98aa2a2b9e4ada5bc">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: OIDP requests feedback on the development of
the following (collectively referred to as the Strategic Plans):
<bullet> National HIV/AIDS Strategy for the United States: 2026-2030
(NHAS)
<bullet> Sexually Transmitted Infections National Strategic Plan for
the United States: 2026-2030 (STI Plan)
<bullet> Vaccines National Strategic Plan for the United States: 2026-
2030 (Vaccines Plan)
<bullet> Viral Hepatitis National Strategic Plan for the United States
2026-2030 (Viral Hepatitis Plan)
The National HIV/AIDS Strategy for the United States: 2022-2025
(<a href="https://files.hiv.gov/s3fs-public/NHAS-2022-2025.pdf">https://files.hiv.gov/s3fs-public/NHAS-2022-2025.pdf</a>), the Sexually
Transmitted Infections National Strategic Plan for the United States:
2021-2025 (<a href="https://www.hhs.gov/sites/default/files/STI-National-Strategic-Plan-2021-2025.pdf">https://www.hhs.gov/sites/default/files/STI-National-Strategic-Plan-2021-2025.pdf</a>), the Vaccines National Strategic Plan:
2021-2025 (<a href="https://www.hhs.gov/sites/default/files/HHS-Vaccines-Report.pdf">https://www.hhs.gov/sites/default/files/HHS-Vaccines-Report.pdf</a>), and the Viral Hepatitis National Strategic Plan for the
United States: A Roadmap to Elimination: 2021-2025 (<a href="https://www.hhs.gov/sites/default/files/Viral-Hepatitis-National-Strategic-Plan-2021-2025.pdf">https://www.hhs.gov/sites/default/files/Viral-Hepatitis-National-Strategic-Plan-2021-2025.pdf</a>) expire at the end of calendar year 2025.
OIDP, in collaboration with the White House Office of National AIDS
Policy (focused specifically on the NHAS) and Federal partners, is
leading work to develop the next iteration of these interrelated
Strategic Plans through 2030. As the next NHAS will be developed in
parallel with the three national strategic plans, OIDP is collecting
information for the 2026-2030 National HIV/AIDS Strategy at the request
of the White House Office of National AIDS Policy. OIDP invites
community input as people have served as the cornerstone for developing
the Strategic Plans since their inception.
Background: The Strategic Plans serve as national roadmaps for a
broad range of constituents to help prevent, diagnose, treat, and cure
disease, improve health outcomes, reduce health disparities and
inequities, and advance research and technology. The plans include a
common vision, overarching goals, objectives, and strategies, and
indicators to measure national progress toward established targets.
The development of the next iteration of the Strategic Plans will
serve as an opportunity to incorporate the latest epidemiological data;
review progress toward achieving national strategic plan goals; center
the needs of populations disproportionately affected; address gaps
identified in existing Strategic Plans; integrate the latest scientific
advances; prioritize the most effective strategies for achieving
national goals; and further emphasize the need to implement integrated
syndemic approaches (<a href="https://www.hiv.gov/blog/defining-the-term-syndemic">https://www.hiv.gov/blog/defining-the-term-syndemic</a>) that cut across each of the Strategic Plans and address
common root causes of infectious diseases.
OIDP, in collaboration with Federal partners, is updating the
Strategic Plans at the same time because these conditions often
disproportionately affect similar populations and may share common root
causes. The Vaccine National Strategic Plan is included in this
coordinated process to elevate the critical role vaccines can serve as
a key intervention to prevent infectious disease, including STIs and
viral hepatitis, and to disrupt syndemics. By updating the Strategic
Plans at the same time, OIDP aims to identify, leverage, and maximize
Federal and other resources to achieve health equity and reduce related
health disparities.
OIDP coordinates the development, implementation, and monitoring of
the Strategic Plans in collaboration with Federal partners.
Information Requested: Anyone can submit written responses to the
questions of interest listed at the following website: <a href="https://app.smartsheetgov.com/b/form/68aa1bd9c54b42829f99e85cc4ab1e82">https://app.smartsheetgov.com/b/form/68aa1bd9c54b42829f99e85cc4ab1e82</a>.
This feedback will inform the 2026-2030 Strategic Plans. Please
note that responses have specified word limits. Please provide
evidence-based justification where applicable. Professional societies,
advocacy organizations, and other groups are encouraged to submit a
single collective response that reflects the views of their membership.
Responses to this RFI Notice are voluntary and may be made public
by HHS. The submitted information will be reviewed by HHS staff and may
be made available to the public, along with the submitting individual's
name, email address, and demographic information consisting of the
submitter's location, affiliated organization, role, and (if provided)
title and nature of comments. Submitted information will not be
considered confidential, so do not include proprietary, classified,
confidential, personal, or other sensitive information in your
response. This request is for information and planning purposes and
should not be construed as a solicitation or as an obligation of the
Federal Government or the HHS. No awards will be made based on
responses to this RFI. The information submitted will be analyzed and
may be used in reports or presentations. Those who respond are advised
that the HHS is under no obligation to acknowledge receipt of your
comments or provide feedback on your submission. The HHS and the
government reserve the right to use any non-proprietary technical
information in any future solicitation(s).
Authority: 42 U.S.C. 202 and 42 U.S.C. 207.
B. Kaye Hayes,
Deputy Assistant Secretary for Infectious Disease; Director, Office of
Infectious Disease and HIV/AIDS Policy.
[FR Doc. 2024-22948 Filed 10-4-24; 8:45 am]
BILLING CODE P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on October 7, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.